Skip to main content

FDA recall, , Moderate risk

Major Pharmaceuticals Midodrine Hydrochloride Tablets

Midodrine Hydrochloride Tablets have defective containers and inadequately sealed blister packaging.

What happened

The Harvard Drug Group LLC of Dublin, Ohio, recalled 8892 cartons of Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets (5 x 10 blister packs), Rx only, packaged and distributed by Major Pharmaceuticals, Indianapolis, IN 46268 USA. The FDA stated the reason as defective container and inadequately sealed blister packaging.

The recall began on February 17, 2026, was added to the FDA's Enforcement Report on March 3, 2026, and was classified by FDA on March 3, 2026. In FDA's weekly enforcement report on March 11, 2026, the recall was listed. The product was distributed nationwide US.

What to do

We don't have product-specific instructions for this recall. FDA's general advice for medicine recalls:

  1. Check the FDA or company notice for instructions specific to this product.
  2. Ask your pharmacist or doctor whether your lot is affected and what to do.

Is yours affected?

Match the NDC and lot code listed under your product.

An NDC (National Drug Code) is usually printed on the drug's label.

  1. Midodrine Hydrochloride Tablets, USP, 5 mg, 50 Tablets

    NDC
    • 0904-6818-06
    Lot code
    • N02640

Recall details

Company began the recall
Sold in

Nationwide US.

Company
The Harvard Drug Group LLCDublin, Ohio
Risk

Moderate risk

Taking it may cause short-term health problems, or ones that treatment can reverse. Serious harm is unlikely.

FDA Class II recall · How risk is rated

Event ID
98456
Recall number
D-0383-2026
Quantity recalled
8892 cartons

All recalls from The Harvard Drug Group LLC

Timeline

FDA's Enforcement Report is its public list of recalls; FDA adds a recall when it posts it and publishes the list weekly.

  1. Company began the recall

  2. Added to FDA's Enforcement Report · Classified by FDA

  3. In FDA's weekly enforcement report

  4. Listed on Recall Canary

  5. Summary updated

Summary by Recall Canary, written with AI · summary updated Oct 3, 2026 · primary source: U.S. Food and Drug Administration (opens in a new tab)